Stay updated on Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange Detected- Expanded and reorganized the Locations section to include a comprehensive list of study sites across multiple countries and U.S. states. - Previous grouped location headings were removed.SummaryDifference2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedMinor version update from v3.3.1 to v3.3.2 with no visible changes to study content.SummaryDifference0.0%

- Check41 days agoChange DetectedA new note states that publications are automatically filled from PubMed and may or may not be about the study. The page revision was updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check48 days agoChange DetectedA new study location, Tainan, Taiwan, 704, was added and the existing Tainan City, Taiwan, 704 was removed. A notice about lapse in government funding related to site operations was deleted.SummaryDifference0.2%

- Check62 days agoChange DetectedNo additions or deletions were detected; the page content remains unchanged.SummaryDifference0.2%

- Check91 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2%

Stay in the know with updates to Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.